عنوان

New Drugs in Cancer Chemotherapy

(Number (ISBN

3642815650

(Number (ISBN

9783642815652

Number

b551126

Title Proper

New Drugs in Cancer Chemotherapy

General Material Designation

[Book]

First Statement of Responsibility

edited by Stephen K. Carter, Yoshi Sakurai, Hamoa Umezawa.

Place of Publication, Distribution, etc.

Berlin, Heidelberg

Name of Publisher, Distributor, etc.

Springer Berlin Heidelberg

Date of Publication, Distribution, etc.

1981

Specific Material Designation and Extent of Item

(xiv, 338 pages)

Series Title

Recent Results in Cancer Research, Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, 76.

Text of Note

The Analog Potential in Cancer Chemotherapy in the United States and Japan --;Anthracyclines --;Preclinical Rationale and Phase I Clinical Trial of the Adriamycin Analog, AD 32 --;Available Data from Carminomycin Studies in the United States: The Acute Intermittent Intravenous Schedule --;New Anthracycline Antibiotic Aclacinomycin A: Experimental Studies and Correlations with Clinical Trials --;Bleomycins --;Current Status of PEP Bleomycin Studies in Japan --;Phase I and II Study of a New Bleomycin Analog (Pepleomycin) --;Tallysomycin, A Third Generation Bleomycin Analog --;Fluorinated Pyrimidines --;Studies of Analogs of Fluorinated Pyrimidine in Japan --;The Pharmacology of Ftorafur (R, S-l-(Tetrahydro-2- Furanyl)-5-Fluorouracil) --;Nitrosoureas --;Current Status of Nitrosoureas Under Development in Japan --;PCNU Phase I Study in the Northern California Oncology Group --;Molecular Pharmacology of Nitrosoureas --;Mechanistic Approaches to New Nitrosourea Development --;Other New Drugs --;New Natural Products Under Development at the National Cancer Institute --;A Prospective Screening Program: Current Screening and its Status --;Selected Anticancer Drugs in Phase I Trials in the United States (1979-1980) --;Fundamental Studies on Bestatin: A Small Molecular Microbial Product Enhancing Immune Responses --;A Review of Clinical Studies on Bestatin, 1976-1978 --;Phase I-II Study of N4-Behenoyl-1-?-D-Arabino-furanosylcytosine --;Gastric Cancer --;The FAM Regimen for Gastric Cancer: A Progress Report --;Adjuvant Studies in Gastric Cancer in the United States --;Preliminary Results of a United States-Japan Cooperative Trial in Patients with Disseminated Gastric Cancer --;Oat Cell Lung Cancer --;Combined Modality Studies on Small Cell Carcinoma of the Lung- Current Status in Japan --;Small Cell Lung Carcinoma --;Recent Advances and Current Challenges --;Head and Neck Cancer --;Combination Chemotherapy of Head and Neck Cancer in the United States --;High-Dose Methotrexate and Cis-Platinum in the Treatment of Recurrent Head and Neck Cancer --;Breast Cancer --;Current Strategy in the Chemotherapy of Advanced Breast Cancer --;Recent Advances in Chemotherapy for Advanced Breast Cancer --;The Current Status of Adjuvant Chemotherapy in Breast Cancer.

Text of Note

San Francisco (USA), May 21-22, 1979. Annual Program Review Symposium / US Japan Joint Agreement on Cancer Research

Parallel Title

San Francisco (USA), May 21-22, 1979. Annual Program Review Symposium / US Japan Joint Agreement on Cancer Research

Medicine.

Oncology.

Toxicology.

edited by Stephen K. Carter, Yoshi Sakurai, Hamoa Umezawa.

Hamoa Umezawa

Stephen K Carter

Yoshi Sakurai

Electronic name

[Book]

Y